Biblio
.
.
.
Self-adjuvant multiepitope nanovaccine based on ferritin induced long-lasting and effective mucosal immunity against H3N2 and H1N1 viruses in mice. Int J Biol Macromol. 2024:129259.
Self-Assembled Multiepitope Nanovaccine Provides Long-Lasting Cross-Protection Against Influenza Virus. Adv Healthc Mater. 2023:e2303531.